0000950170-23-073331.txt : 20231227 0000950170-23-073331.hdr.sgml : 20231227 20231227164743 ACCESSION NUMBER: 0000950170-23-073331 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231222 FILED AS OF DATE: 20231227 DATE AS OF CHANGE: 20231227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Falcon Fund 2 Holding Company, L.P. CENTRAL INDEX KEY: 0001817718 ORGANIZATION NAME: STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35887 FILM NUMBER: 231518478 BUSINESS ADDRESS: STREET 1: 21 WATERWAY AVENUE STREET 2: SUITE 225 CITY: THE WOODLANDS STATE: TX ZIP: 77380 BUSINESS PHONE: 2813641555 MAIL ADDRESS: STREET 1: 21 WATERWAY AVENUE STREET 2: SUITE 225 CITY: THE WOODLANDS STATE: TX ZIP: 77380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MIMEDX GROUP, INC. CENTRAL INDEX KEY: 0001376339 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 262792552 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1775 W OAK COMMONS COURT, NE CITY: MARIETTA STATE: GA ZIP: 30062 BUSINESS PHONE: (770) 651-9100 MAIL ADDRESS: STREET 1: 1775 W OAK COMMONS COURT, NE CITY: MARIETTA STATE: GA ZIP: 30062 FORMER COMPANY: FORMER CONFORMED NAME: Alynx, Co. DATE OF NAME CHANGE: 20060922 4 1 ownership.xml 4 X0508 4 2023-12-22 0001376339 MIMEDX GROUP, INC. MDXG 0001817718 Falcon Fund 2 Holding Company, L.P. 21 WATERWAY AVENUE, SUITE 225 THE WOODLANDS TX 77380 false false true false false Common Stock, par value $0.001 per share 2023-12-22 4 C false 28195249 A 28195249 D Series B Preferred Stock, par value $0.001 per share 3.85 2023-12-22 4 C false 90000 D Common Stock 28195249 0 D On December 22, 2023, all 90,000 shares of Series B Preferred Stock, par value $0.001 per share, with a liquidation preference of $1,000.00 per share ("Series B Preferred Stock"), of MiMedx Group, Inc. (the "Issuer") held by Falcon Fund 2 Holding Company, L.P. (the "Reporting Person"), which were previously acquired by the Reporting Person on June 30, 2020, mandatorily converted into an aggregate 28,195,249 shares of common stock, par value $0.001 per share ("Common Stock"), of the Issuer, in accordance with the terms of the Series B Preferred Stock, which amount is inclusive of 4,818,626 shares of Common Stock issuable to the Reporting Person as a dividend. Falcon Fund 2 Holding Company, L.P., a Delaware limited partnership; By: EW Healthcare Partners Fund 2-UGP, LLC, its general partner; By: Martin P. Sutter, Authorized Signatory /s/ Martin P. Sutter 2023-12-27